30 closest matches · ranked by relevance
HIV Infections · Viral Load · Patient Compliance
Primary: Linkage to HIV Care (Indicated by a HIV-related Laboratory Blood Test Within 8 Months) — 88; 74; 93; 90 Participants
Human Immunodeficiency Virus
Primary: Plasma Viral Load Suppression — 26; 23; 23; 24 participants
HIV/AIDS
Primary: CD4 Cell Count — 996; 1049 cells/mm^3
HIV
Primary: Number of Participants Willing to Undergo Rapid HIV Testing — 318; 60 Participants
HIV/AIDS
Primary: Participants With HIV Viral Load Suppression (Copies/cc) — 114; 128; 38; 32 Participants
HIV/AIDS · HIV Infections · Substance Use
Primary: Total Number of Unprotected Anal and Vaginal Sex Occasions in Past 3 Months — 32.76; 44.00; 27.70; 32.76 unprotected sex occasions — p=0.635
HIV/AIDS
Primary: Number of HIV Care Visits — 1.00; 3.00 HIV Care Visits
Hepatitis C · Drug Users · Harm Reduction
Primary: Percentage of HCV Infected Paticipants Whom Result of the Test Was Delivered to — 101 Participants
HIV/AIDS
Primary: Mortality at 6 Months — 4; 10; 3; 4 Participants
Schizophrenia · Psychotic Disorders · Substance-Related Disorders
Primary: Treatment Engagement — 4.2; 1.4; 7.2; 1.5 number of treatment sessions attended — p=<0.001
HIV Infection · Drug Use
Primary: Undetectable HIV Viral Load at 12 Months — 46.9; 22.7 percentage of participants
Hepatitis C · HIV Infections · Opioid-use Disorder
Primary: Acceptability of Intervention — 13; 6; 0; 0 Participants
Hepatitis C · People Who Inject Drugs · PWID
Primary: Proportion of Patients to Achieve SVR12 at 1 Year — 55; 19 Participants — p=<.001
Tuberculosis, Pulmonary · Rifampicin Resistant Tuberculosis
Primary: Number Treated for Microbiologically-confirmed TB Within 14 Days After Presentation to the Health Center for TB Evaluation — 220; 342 Participants
Motivational Interviewing
Primary: COVID-19 Testing — 69; 47 Participants — p=<0.05
HIV/AIDS · Hospitalization · Transitions of Care
Primary: Post-Discharge Visits — 92 Participants
Primary Care Appointment Keeping
Primary: The Percentage of Patients Attending a Primary Care Visit in Each of 3 Four-month Periods (First Measure) — 55.8; 55.6; 45.7 percent in care each 4 month period
Human Immunodeficiency Virus
Primary: Number of Patients Who Receive Rapid HIV Treatment Initiation — 32 Participants
HIV Infections
Primary: Self-Reported ART Adherence — 56.67; 58.7 Percentage of successful doses
HIV
Primary: Number of Participants Completing HIV Self-Testing — 878; 889; 857; 875 Participants
COVID-19
Primary: Completion of COVID-19 Test — 72; 60 Participants
HIV/AIDS
Primary: Retention in Care - Yes Responses — 19; 23 Participants
Cancer · Physical Inactivity
Primary: The Number of Patients Referred Using the Secure Webform — 54 Participants
Hiv · Adherence, Patient
Primary: Number of Participants in Care at Six Months — 67; 19 Participants
Alcohol Dependence · Drug Dependence
Primary: Rates of Substance Use — 91.1; 88.0 percentage of days
HIV
Primary: Linkage to Care - Participants Who Received Cluster of Differentiation 4 (CD4) T-cell Count Test Result Within 3 Months of Testing HIV-positive (Binary) — 80; 121; 119…
HIV
Primary: Cumulative Incidence of ART Initiation 14 Days After Clinical Eligibility in Treatment Eligible HIV-infected Patients — 2585; 3753 participants
Human Immunodeficiency Virus
Primary: Index Client Fidelity Assessment — 66.30; 45.70 score on a scale — p=<0.001
HIV/AIDS · Hypertension · Hyperlipidemias
Primary: Systolic Blood Pressure — 134.9; 134.9; 129.9; 136.3 model estimated mmhg
Linkage to Care · Homelessness · Substance Use Disorder
Primary: Substance Use Care — 37; 7 Participants